Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16552-98-0

Post Buying Request

16552-98-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16552-98-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 16552-98-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,5,5 and 2 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 16552-98:
(7*1)+(6*6)+(5*5)+(4*5)+(3*2)+(2*9)+(1*8)=120
120 % 10 = 0
So 16552-98-0 is a valid CAS Registry Number.

16552-98-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,1-dimethyl-3-[(E)-pyridin-2-ylmethylideneamino]thiourea

1.2 Other means of identification

Product number -
Other names Carbamic acid,dimethylthio-,(2-pyridylmethylene)hydrazide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16552-98-0 SDS

16552-98-0Downstream Products

16552-98-0Relevant articles and documents

Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands

Deng, Jungang,Yu, Ping,Zhang, Zhenlei,Wang, Jun,Cai, Jinhua,Wu, Na,Sun, Hongbin,Liang, Hong,Yang, Feng

, p. 442 - 452 (2018)

To develop potential next-generation metal anticancer agents, we designed and synthesised five Cu(II) 2-pyridine-thiosemicarbazone complexes by modifying the hydrogen atom at the N-4 position of ligands, and then investigated their structure-activity rela

Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment Components

Chu, Yong,Jiang, Ming,Li, Wenjuan,Liang, Hong,Sun, Hongbin,Yang, Feng,Yang, Tongfu,Zhang, Zhenlei

, p. 14587 - 14602 (2021/10/25)

To overcome the resistance of cancer cells to platinum-based drugs and effectively suppress tumor growth, we developed a novel indium (In) agent based on liposomes (Lips). Thus, we not only obtained an In(III) thiosemicarbazone agent (5b) with remarkable

Tin complex with 2-pyridineformaldehyde thiosemicarbazone as ligand and synthesis method thereof

-

Paragraph 0044-0047, (2020/02/14)

The invention discloses a tin complex taking 2-pyridineformaldehyde thiosemicarbazone as a ligand and a synthesis method thereof. The synthesis method comprises the following steps of: dissolving thiosemicarbazone in anhydrous CH3OH, adding 2-pyridineform

Indium compound taking 2-pyridylaldehyde thiosemicarbazone as ligand as well as synthesis method and application thereof

-

Paragraph 0049-0052, (2019/06/12)

The invention discloses an indium compound taking 2-pyridylaldehyde thiosemicarbazone as a ligand as well as a synthesis method and application thereof. The synthesis method comprises the following steps: dissolving thiosemicarbazide into methanol; after

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16552-98-0